Carbometrics

Executive Summary

Carbometrics is a UK-based diagnostics and digital health company developing advanced synthetic glucose sensors inspired by nature. Founded in 2018 and headquartered in Bristol, the company focuses on creating highly selective and durable continuous glucose monitors (CGMs) for both wearable and implantable applications. Their technology uses molecular recognition to mimic natural biological sensing, aiming to overcome limitations of current enzymatic-based sensors, such as poor longevity and drift. Carbometrics' sensors are designed to provide accurate, real-time glucose monitoring for diabetes management, potentially improving patient outcomes and quality of life. As an early-stage private company, Carbometrics has not disclosed specific funding or valuation details, but its innovative approach positions it in a growing market where demand for non-invasive and reliable CGM solutions is high. While still in the development phase, the company's synthetic sensor platform could offer significant advantages over traditional CGMs, including enhanced stability, reduced calibration needs, and longer wear time. The next 12-18 months will be critical for demonstrating proof-of-concept and attracting strategic partnerships or investment to advance toward commercialization.

Upcoming Catalysts (preview)

• Q4 2026Prototype Validation Results60% success
• Q1 2027Strategic Partnership for Sensor Integration50% success
• Q2 2027Series A Funding Round Completion45% success